61. Groundbreaking immunology microbe oral therapies, Simba Gill, CEO, Evelo Biosciences

episode

Biotech 2050 Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Start A Blessing | Joel Osteen 31 min · 29 Sep 2026 · Joel Osteen Podcast

Peter O'Mahony in studio | Why Munster need big changes, Joe & Andy, mouthy Scotland 59 min · 29 Sep 2026 · Indo Sport

Ari Emanuel: What Hollywood’s Ultimate Power Broker Knows About Succeeding Against the Odds 51 min · 29 Sep 2026 · Aspire with Emma Grede

NPR News: 09-29-2026 8AM EDT 5 min · 29 Sep 2026 · NPR News Now

John Paul DeJoria- From Homeless to Billionaire 40 min · 29 Sep 2026 · THE ED MYLETT SHOW

EP 130: Gerry Hopkinson Sold His Agency, Stayed Five Years, And Became A Cultural Strategist 56 min · 29 Sep 2026 · Embracing Marketing Mistakes

Report any issue

Source

Recorded16 Jun 2021

Publisherfeeds.soundcloud.com ↗

Handlerec:2866942

Show notes

Balkrishan (Simba) Gill, Ph.D. has served as our President, Chief Executive Officer and a member of our Board of Directors since September 2015. Dr. Gill also has served on the board of directors of Realm Therapeutics PLC since 2016, and as a Venture Partner at Flagship Pioneering, a life sciences innovation enterprise, since 2015. From 2006 to 2015, Dr. Gill served as the President and Chief Executive Officer of moksha8 Pharmaceuticals, Inc., a pharmaceutical company. From 2016 to 2019, Dr. Gill served as a director at Realm Therapeutics PLC. Dr. Gill received his Ph.D. from King’s College, London and his M.B.A. from INSEAD.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in